AmerisourceBergen elevates Steve Collis to president and COO
The Big Three distributor’s board of directors has appointed Collis, currently president of AmerisourceBergen Drug Corp. (ABDC, the pharma wholesaling arm of the company) to president and chief operating officer of the parent. He will report to R. David Yost, AmerisourceBergen’s CEO, who previously also held the title of president.
Collis is now responsible for all AmerisourceBergen business units, including ABDC, AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Packaging Group (ABPG) and AmerisourceBergen Consulting Services (ABCS). ABSG and ABCS previously reported to Yost, and ABPG previously reported to Michael DiCandilo, EVP and CFO.
Collis, who has been at AmerisourceBergen for 16 years, has been president of ABSG since 1999; that unit is now a fast-growing, $16-billion part of the company. This month, the company also announced its FY2010 results, with revenue reaching a new record, $78.0 billion, up 8.6%, and gross profit of $2.4 billion, up 12.2%.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
